SAN DIEGO, Sept. 8, 2025 /PRNewswire/ -- Robbins LLP informs stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Savara Inc. (NASAQ: SVRA) ...

Guaranty Bancshares, Inc. (NYSE: GNTY) related to its sale to Glacier Bancorp, Inc. Upon completion of the proposed transaction, existing Guaranty shareholders will receive 1.0000 share of Glacier ...

or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit ...

This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Novo Nordisk ...

North Dakota State men's basketball has added a little bit of size to its 2026 recruiting class. The Bison have their fourth commit of the upcoming class as Highlands Ranch, Colo. forward Oliver ...

The hilarious and food-loving Raphael Gomes takes a hands-on lesson in edible art during a rice bento box class in Japan. Bruce Willis’s wife makes ‘hardest decision’ to move star out of family home ...

We’ve sent a link to to change your password. Please check your inbox to reset your password securely and easily.

In an unexpected addition to Indiana's pregame injury report for its clash against league-leading Minnesota, forward Chloe Bibby has been scratched and is unavailable Friday night. Fever coach ...

According to the complaint, during the class period, defendants created the false impression that they possessed reliable information pertaining to the Company's expected advertising revenue and ...

This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Altimmune ...

The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that: (1) Novo Nordisk's representations regarding its ...